Delivery Order SPE2DB24D2013-SPE2DB25FCJGR
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.38 Firm Fixed Price Delivery Order contract is for the supply of Glipizide-Metformin 2.5-500 mg tablets, a medication used to treat diabetes. The contract has a period of performance through July 1, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,968.16, is for the delivery of Glipizide-Metformin 5-500 mg tablets over a period ending on April 15, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award, identified as SPE2DB20D3103|SPE2DB25FL8A6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,009.97, is for the delivery of Glipizide-Metformin 2.5-500 mg tablets, a medication used to treat type 2 diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a Firm Fixed Price pricing type and a ceiling value of $2,155.92. It is not designated as a set-aside contract. The contract provides for the delivery of GLYBURIDE-METFORMIN 5-500 MG 100S, a pharmaceutical product used for the treatment of diabetes. This Delivery Order is part of a larger...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Glipizide-Metformin 2.5-500 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,283.96, has a period of performance through May 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Glyburide-Metformin 5-500 mg medication, with a ceiling value of $1,465.70 and an ultimate completion date of October 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glyburide-Metformin 5-500 mg medication. The contract has a ceiling value of $23,674.31 and a period of performance through April 28, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., also...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,706.91 and is for the delivery of 4,564,200 tablets of glipizide extended-release 10 mg, a medication used to treat type 2 diabetes. The contract is a firm-fixed-price arrangement with an ultimate completion date of April 9, 2024. This delivery order is part of a larger...
This is a $5,299.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pioglitazone-Metformin 15-850 60S, a medication used to manage diabetes. The contract has an ultimate completion date of December 26, 2023. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 2 mg tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $1,451.32 and a period of performance through April 28, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen...